$54.6B
$5.92 Million
0.06% of portfolio
216,535
Q3 2022
Reduced 89.42%
$1.88B
$4.86 Million
0.05% of portfolio
330,472
Q3 2022
Reduced 14.8%
$151B
$5.12 Million
0.05% of portfolio
174,546
Q3 2022
Added 0.64%
$48.3B
$5.74 Million
0.05% of portfolio
57,859
Q3 2022
Added 122.85%
$34.6B
$5.45 Million
0.05% of portfolio
30,922
Q3 2022
Added 3.1%
$4.25B
$5.05 Million
0.05% of portfolio
185,000
Q3 2022
Added 85.0%
$25.8B
$5.57 Million
0.05% of portfolio
37,114
Q1 2022
Reduced 19.18%
$7.2B
$5.18 Million
0.05% of portfolio
28,107
Q3 2022
New
$121B
$5.03 Million
0.05% of portfolio
60,038
Q3 2022
Reduced 16.97%
$155B
$5.43 Million
0.05% of portfolio
66,252
Q3 2022
Reduced 95.15%
Esperion Therapeutics Inc.
-
$5.77 Million
0.05% of portfolio
-
Q2 2022
Added 48.93%
$7.74B
$5.77 Million
0.05% of portfolio
131,303
Q3 2022
Reduced 1.58%
$6.73B
$5.67 Million
0.05% of portfolio
25,596
Q3 2022
Reduced 6.52%
$82.5B
$4.84 Million
0.05% of portfolio
33,397
Q3 2022
Added 2.06%
$41.7B
$5.08 Million
0.05% of portfolio
63,259
Q3 2022
Reduced 13.94%
$2.31B
$5.19 Million
0.05% of portfolio
99,120
Q3 2022
New
-
$4.18 Million
0.04% of portfolio
-
Q1 2022
New
$2.47B
$4.36 Million
0.04% of portfolio
145,778
Q3 2022
Added 29.56%
Pioneer Natural Resources Co.
-
$3.75 Million
0.04% of portfolio
-
Q3 2022
Reduced 14.36%
$1.29B
$4.08 Million
0.04% of portfolio
125,000
Q1 2022
New
$5.88B
$3.94 Million
0.04% of portfolio
21,180
Q3 2022
Added 48.32%
$4.64B
$4.7 Million
0.04% of portfolio
215,000
Q3 2021
New
$149B
$3.75 Million
0.04% of portfolio
19,266
Q3 2022
Reduced 92.98%
$120B
$3.91 Million
0.04% of portfolio
63,326
Q3 2022
New
-
$4.57 Million
0.04% of portfolio
-
Q3 2022
Added 83.33%
$11.2B
$4.49 Million
0.04% of portfolio
94,706
Q3 2022
Reduced 75.54%
-
$4.13 Million
0.04% of portfolio
-
Q3 2022
New
$35.6B
$3.99 Million
0.04% of portfolio
95,017
Q3 2022
Added 12.31%
-
$4 Million
0.04% of portfolio
-
Q3 2022
New
-
$4.65 Million
0.04% of portfolio
-
Q3 2022
Added 38.8%
-
$3.66 Million
0.03% of portfolio
-
Q3 2022
Added 102.04%
$22.8B
$3.68 Million
0.03% of portfolio
183,434
Q2 2022
Reduced 45.7%
-
$2.76 Million
0.03% of portfolio
-
Q1 2022
Reduced 38.46%
$4.71B
$3.53 Million
0.03% of portfolio
108,139
Q1 2022
Added 163.55%
Paratek Pharmaceuticals Inc.
-
$3.54 Million
0.03% of portfolio
-
Q4 2021
New
Microchip Technology Inc.
-
$3.42 Million
0.03% of portfolio
-
Q1 2022
Reduced 12.22%
World Wrestling Entertainment Inc.
-
$2.79 Million
0.03% of portfolio
-
Q1 2022
Reduced 1.5%
$44.8B
$3.22 Million
0.03% of portfolio
76,314
Q3 2022
Reduced 4.37%
$34.1B
$2.84 Million
0.03% of portfolio
33,142
Q3 2022
Reduced 31.39%
$29.9B
$2.93 Million
0.03% of portfolio
90,575
Q3 2022
Reduced 2.54%
-
$3.2 Million
0.03% of portfolio
-
Q1 2022
Reduced 50.5%
$15.9B
$3.17 Million
0.03% of portfolio
65,580
Q1 2022
Reduced 17.9%
$695M
$3.55 Million
0.03% of portfolio
125,000
Q3 2022
New
$28.1B
$3.7 Million
0.03% of portfolio
30,715
Q1 2022
Added 18.96%
-
$3.67 Million
0.03% of portfolio
-
Q2 2022
Added 15.0%
$22.2B
$3.24 Million
0.03% of portfolio
11,388
Q3 2022
Reduced 19.17%
$30B
$3.6 Million
0.03% of portfolio
16,219
Q1 2022
Reduced 29.25%
-
$2.67 Million
0.03% of portfolio
-
Q2 2022
New
$15.7B
$2.72 Million
0.03% of portfolio
19,371
Q3 2022
Added 2.06%
-
$3.68 Million
0.03% of portfolio
-
Q3 2022
Added 108.0%